Asymmetric triplex metallohelices with high and selective activity against cancer cells

Nature Chemistry

Volumn 6, Issue 9, 2014, Pages 797-803

  Faulkner, Alan D ^a   Kaner, Rebecca A ^a   Abdallah, Qasem M A ^b   Clarkson, Guy ^a   Fox, David J ^a   Gurnani, Pratik ^a   Howson, Suzanne E ^a   Phillips, Roger M ^c   Roper, David I ^a   Simpson, Daniel H ^a   Scott, Peter ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b TAIF UNIVERSITY   (Saudi Arabia)

^c UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CHEMISTRY; DNA DAMAGE; DRUG DESIGN; HCT116 CELL LINE; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN SECONDARY STRUCTURE; SYNTHESIS;

ANTINEOPLASTIC AGENTS; DNA DAMAGE; DRUG DESIGN; HCT116 CELLS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN STRUCTURE, SECONDARY;

EID: 84906565704     PISSN: 17554330     EISSN: 17554349     Source Type: Journal    
DOI: 10.1038/nchem.2024     Document Type: Article

References (50)

1. Zanetti M. Gennaro R. & Romeo D. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett. 374 1-5 (1995).
2. Lane D. P. p53 guardian of the genome. Nature 358 15-16 (1992).
3. Dürr U. H. N. Sudheendra U. S. & Ramamoorthy A. LL-37 the only human member of the cathelicidin family of antimicrobial peptides. Biochim. Biophys. Acta Biomembr. 1758 1408-1425 (2006).
4. Wu W. K. K. et al. Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications. Int. J. Cancer 127 1741-1747 (2010).
5. Baker S. J. et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244 217-221 (1989).
6. Takahashi T. et al. p53: a frequent target for genetic abnormalities in lung cancer. Science 246 491-494 (1989).
7. Walensky L. D. et al. Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix. Science 305 1466-1470 (2004).
8. Gavathiotis E. et al. BAX activation is initiated at a novel interaction site. Nature 455 1076-1081 (2008).
9. Cheng R. P. Gellman S. H. & DeGrado W. F. Beta-peptides: from structure to function. Chem. Rev. 101 3219-3232 (2001).
10. Appella D. H. Christianson L. A. Karle I. L. Powell D. R. & Gellman S. H. Beta-peptide foldamers: robust helix formation in a new family of beta-amino acid oligomers. J. Am. Chem. Soc. 118 13071-13072 (1996).
11. Johnson L. M. & Gellman S. H. in Methods in Enzymology (ed. Keating A. E.) 407-429 (Methods in Protein Design series Vol. 523 Academic 2013).
12. Davis J. M. Tsou L. K. & Hamilton A. D. Synthetic non-peptide mimetics of alpha-helices. Chem. Soc. Rev. 36 326-334 (2007).
13. Azzarito V. Long K. Murphy N. S. & Wilson A. J. Inhibition of α-helixmediated protein-protein interactions using designed molecules. Nature Chem. 5 161-173 (2013).
14. Lehn J. M. et al. Spontaneous assembly of double-stranded helicates from oligobipyridine ligands and copper(I) cations: structure of an inorganic double helix. Proc. Natl Acad. Sci. USA 84 2565-2569 (1987).
15. Albrecht M. & Fröhlich R. Controlling the orientation of sequential ligands in the self-assembly of binuclear coordination compounds. J. Am. Chem. Soc. 119 1656-1661 (1997).
16. Torelli S. Delahaye S. Hauser A. Bernardinelli G. & Piguet C. Ruthenium(II) as a novel labile partner in thermodynamic self-assembly of heterobimetallic d-f triple-stranded helicates. Chem. Eur. J. 10 3503-3516 (2004).
17. Hahn F. E. Schulze Isfort C. & Pape T. A dinuclear triple-stranded helicate with a diamide-bridged catechol/benzenedithiol ligand. Angew. Chem. Int. Ed. 43 4807-4810 (2004).
18. Rice C. R. Baylies C. J. Jeffery J. C. Paul R. L. &Ward M. D. Mononuclear Cu (II) and triple helical dinuclear Co(II) complexes of a new potentially tetradentate ligand containing inequivalent bidentate units. Inorg. Chim. Acta 324 331-335 (2001).
19. Hannon M. J. Bunce S. Clarke A. J. & Alcock N. W. Spacer control of directionality in supramolecular helicates using an inexpensive approach. Angew. Chem. Int. Ed. 38 1277-1278 (1999).
20. Constable E. C. Heirtzler F. R. Neuburger M. & Zehnder M. Directional ligands in helicate selfassembly. Supramol. Chem. 5 197-200 (1995).
21. Albrecht M. Napp M. Schneider M. Weis P. & Frohlich R. Kinetic thermodynamic control of the self-assembly of isomeric double-stranded dinuclear titanium(IV) complexes from a phenylalanine-bridged dicatechol ligand. Chem. Commun. 409-410 (2001).
22. Schulze Isfort C. Kreickmann T. Pape T. Frohlich R. & Hahn F. E. Helical complexes containing diamide-bridged benzene-o-dithiolato/catecholato ligands. Chemistry 13 2344-2357 (2007).
23. Howson S. E. & Scott P. Approaches to the synthesis of optically pure helicates. Dalton Trans. 40 10268-10277 (2011).
24. Kerckhoffs J. M. C. A. et al. Enantiomeric resolution of supramolecular helicates with different surface topographies. Dalton Trans. 734-742 (2007).
25. Hotze A. C. G. et al. Supramolecular iron cylinder with unprecedented DNA binding is a potent cytostatic and apoptotic agent without exhibiting genotoxicity. Chem. Biol. 15 1258-1267 (2008).
26. Cardo L. Sadovnikova V. Phongtongpasuk S. Hodges N. J. & Hannon M. J. Arginine conjugates of metallo-supramolecular cylinders prescribe helicity and enhance DNA junction binding and cellular activity. Chem. Commun. 47 6575-6577 (2011).
27. Yu H. et al. Metallosupramolecular complex targeting an α/β discordant stretch of amyloid β peptide. Chem. Sci. 3 3145-3153 (2012).
28. Howson S. E. et al. Origins of stereoselectivity in optically pure phenylethaniminopyridine tris-chelates M(NN')3 n+ (M=Mn Fe Co Ni and Zn). Dalton Trans. 40 10416-10433 (2011).
29. Howson S. E. et al. Self-assembling optically pure Fe(A-B)3 chelates. Chem. Commun. 1727-1729 (2009).
30. Howson S. E. et al. Jahn-Teller effects on p-stacking and stereoselectivity in the phenylethaniminopyridine tris-chelates Cu(NN')3 2+. Dalton Trans. 41 4477-4483 (2012).
31. Howson S. E. et al. Optically pure heterobimetallic helicates from self-assembly and click strategies. Dalton Trans. 42 14967-14981 (2013).
32. Howson S. E. et al. Optically pure water-stable metallo-helical 'flexicate' assemblies with antibiotic activity. Nature Chem. 4 31-36 (2012).
33. Brabec V. et al. Metallohelices with activity against cisplatin-resistant cancer cells; does the mechanism involve DNA binding? Chem. Sci. 4 4407-4416 (2013).
34. Hunter C. A. & Sanders J. K. M. The nature of π-π interactions. J. Am. Chem. Soc. 112 5525-5534 (1990).
35. Grimme S. Do special noncovalent π-π stacking interactions really exist? Angew. Chem. Int. Ed. 47 3430-3434 (2008).
36. Hannon M. J. Painting C. L. Jackson A. Hamblin J. & Errington W. An inexpensive approach to supramolecular architecture. Chem. Commun. 1807-1808 (1997).
37. Ren S. X. et al. FK-16 derived from the anticancer peptide LL-37 induces caspase-independent apoptosis and autophagic cell death in colon cancer cells. PLoS ONE 8 e63641 (2013).
38. Fu D. Calvo J. A. & Samson L. D. Balancing repair and tolerance of DNA damage caused by alkylating agents. Nature Rev. Cancer 12 104-120 (2012).
39. Siddik Z. H. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22 7265-7279 (2003).
40. Bonner W. M. et al. γH2AX and cancer. Nature Rev. Cancer 8 957-967 (2008).
41. Krishan A. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol. 66 188-193 (1975).
42. Nicoletti I. Migliorati G. Pagliacci M. C. Grignani F. & Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139 271-279 (1991).
43. Kajstura M. Halicka H. D. Pryjma J. & Darzynkiewicz Z. Discontinuous fragmentation of nuclear DNA during apoptosis revealed by discrete 'sub-G1' peaks on DNA content histograms. Cytometry A 71A 125-131 (2007).
44. Grimme S. Ehrlich S. & Goerigk L. Effect of the damping function in dispersion corrected density functional theory. J. Comput. Chem. 32 1456-1465 (2011).
45. Granovsky A. A. Firefly version 7.1.G; http://classic.chem.msu.su/gran/ firefly/index.html
46. Schmidt M. W. et al. General atomic and molecular electronic structure system. J. Comput. Chem. 14 1347-1363 (1993).
47. Deeth R. J. Anastasi A. Diedrich C. & Randell K. Molecular modelling for transition metal complexes: dealing with d-electron effects. Coord. Chem. Rev. 253 795-816 (2009).
48. Deeth R. J. Fey N. & Williams-Hubbard B. DommiMOE: an implementation of ligand field molecular mechanics in the molecular operating environment. J. Comput. Chem. 26 123-130 (2005).
49. Andrews J. M. Determination of minimum inhibitory concentrations. J. Antimicrob. Chemother. 48 5-16 (2001).
50. Coles S. J. & Gale P. A. Changing and challenging times for service crystallography. Chem. Sci. 3 683-689 (2012).